Integra LifeSciences Holdings Corporation (NASDAQ:IART) is set to announce third quarter earning results on Wednesday 28th October 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, IART to report 3Q20 income of $ 0.53 per share.
For the full year, analysts anticipate top line of $ 1355.16 million, while looking forward to income of $ 2.07 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 368.00 million ~ $ 370.00 million
Full Year 2020 topline are forecasted in a range of$ 1,550.00 million ~ $ 1,570.00 million, where as bottomline are predicted in a range of $ 3.00 ~ $ 3.05 per share
Click Here For More Historical Outlooks Of Integra LifeSciences Holdings Corporation
Previous Quarter Performance
Integra LifeSciences Holdings Corporation outlined income for the second quarter of $ 0.33 per share, from the revenue of $ 258.67 million. The quarterly earnings decreased 54.79 percent while revenues declined 32.58 percent compared with the same quarter last year.
Wall street analysts are predicting, IART to report 2Q20 income of $ 0.10 per share from revenue of $ 242.80 million. The bottom line results beat street analysts by $ 0.23 or 230.00 percent, at the same time, top line results outshined analysts by $ 15.87 million or 6.54 percent.
Stock Performance
Shares of Integra LifeSciences Holdings Corporation traded low $ -0.92 or -1.94 percent on Tuesday, reaching $ 46.55 with volume of 445.90 thousand shares. Integra LifeSciences Holdings Corporation has traded high as $ 48.07 and has cracked $ 46.16 on the downward trend
According to the previous trading day, closing price of $ 46.55, representing a 38.76 % increase from the 52 week low of $ 34.21 and a 24.92 % decrease over the 52 week high of $ 63.23.
The company has a market capital of $ 3.92 billion and is part of the Healthcare sector and Medical Devices industry.
Recent Analyst recommendations
- On 8th October 2020, downgraded by JPMorgan Chase & Co. to Underweight from Neutral rating.
Conference Call
Integra LifeSciences Holdings Corporation will be hosting a conference call at 8:30 AM eastern time on 28th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.integralife.com
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.
